Nektar Therapeutics
NKTR
$1.46
Share price
10.98%
Change (1 day)
95.33%
Change (1 year)
Categories
Nektar Therapeutics (NKTR) - P/B ratio
P/B ratio as of April 2024 : 1.85
According to Nektar Therapeutics
's latest financial reports the company has a price-to-book ratio of 1.85.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Nektar Therapeutics - P/B ratio (from 2001 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 0.8229 | -28.98% |
| 2022-12-31 | 1.16 | -68.43% |
| 2021-12-31 | 3.67 | 29.62% |
| 2020-12-31 | 2.83 | 4.43% |
| 2019-12-31 | 2.71 | -18.37% |
| 2018-12-31 | 3.32 | -96.9% |
| 2017-12-31 | 107 | 403.16% |
| 2016-12-31 | 21.3 | -94% |
| 2015-12-31 | 355 | 533.42% |
| 2014-12-31 | 56.0 | -480.63% |
| 2013-12-31 | -14.7 | -180.96% |
| 2012-12-31 | 18.2 | 461.25% |
| 2011-12-31 | 3.24 | -75.84% |
| 2010-12-31 | 13.4 | 57.74% |
| 2009-12-31 | 8.49 | 214.19% |
| 2008-12-31 | 2.70 | -6.41% |
| 2007-12-31 | 2.89 | -52.77% |
| 2006-12-31 | 6.11 | 38.42% |
| 2005-12-31 | 4.42 | 20.6% |
| 2004-12-31 | 3.66 | -21.37% |
| 2003-12-31 | 4.66 | 114.58% |
| 2002-12-31 | 2.17 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.12 | 176.73% | 🇺🇸 USA |
 Pfizer PFE | 1.61 | -12.95% | 🇺🇸 USA |
 Amgen AMGN | 23.2 | 1,155.78% | 🇺🇸 USA |
 Baxter BAX | 2.41 | 30.45% | 🇺🇸 USA |
 Merck MRK | 8.83 | 377.22% | 🇺🇸 USA |
 AstraZeneca AZN | 6.21 | 235.86% | 🇬🇧 UK |
 Richardson Electronics RELL | 0.8996 | -51.38% | 🇺🇸 USA |
 Alkermes ALKS | 3.47 | 87.62% | 🇮🇪 Ireland |